➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Boehringer Ingelheim
McKesson
Baxter
Harvard Business School

Last Updated: October 19, 2020

DrugPatentWatch Database Preview

Details for Patent: 6,403,609

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,403,609
Title: Ophthalmic compositions containing galactomannan polymers and borate
Abstract:The present invention is directed to ophthalmic compositions containing a gelling amount of a combination of galactomannan polysaccharides and borates. The compositions gel or partially gel upon administration to the eye. The present invention also discloses methods of topical ophthalmic administration of the compositions of the eye.
Inventor(s): Asgharian; Bahram (Arlington, TX)
Assignee: Alcon Manufacturing, Ltd. (Fort Worth, TX)
Application Number:09/423,762
Patent Claim Types:
see list of patent claims
Composition; Use; Delivery;

Drugs Protected by US Patent 6,403,609

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,403,609

PCT Information
PCT FiledJuly 17, 1998PCT Application Number:PCT/US98/14596
PCT Publication Date:February 11, 1999PCT Publication Number: WO99/06023

International Family Members for US Patent 6,403,609

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 013272   Start Trial
Austria 250923   Start Trial
Austria 391492   Start Trial
Australia 737442   Start Trial
Australia 8570598   Start Trial
Brazil 9811574   Start Trial
Canada 2296080   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Mallinckrodt
Harvard Business School
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.